Brazil Medical Device Registration · BRH Transfer · RDC 903/2024
Change Your Brazilian Registration Holder Without Disrupting Supply
Change your Brazilian Registration Holder without disruption—Sobel documents the successor/previous flow, files the transfer, and plans the label/IFU switchover.
We help you execute a compliant, auditable change of Brazilian Registration Holder (BRH) under ANVISA rules. Sobel structures the successor and previous holder petitions, maps the transfer to RDC 903/2024 and ANVISA’s transfer service, and plans the label/IFU changeover so market continuity is preserved and documentation stands up in audits.
Successor & previous holder flow documented
RDC 903/2024-aligned transfer
Label/IFU changeover planned
When a BRH Change Becomes a Priority
Typical situations where a structured BRH transfer is safer than ad-hoc arrangements:
- You want to consolidate registrations under a single, independent BRH after years of fragmented licenses.
- You are exiting a BRH relationship due to performance, commercial changes, or loss of trust and need a clean, documented transition.
- You are completing a merger or acquisition and need registrations in Brazil to reflect the new ownership structure.
- You must show auditors and authorities that the change of holder followed ANVISA rules, with clear dates and evidence.
- You want to avoid any disruption to import, distribution, or stock movement in Brazil while the holder changes.
Why BRH Transfer Is a Legal and Operational Risk Point
A BRH transfer is not just an internal contract change—it is a legal change of the registration holder before ANVISA.
Without a mapped process, companies risk inconsistent labeling, undocumented decisions, and unresolved questions in audits or inspections.
What You Will Receive
The output is a set of concrete, transfer-focused documents that make the BRH change traceable and audit-ready.
Transfer Dossier (Draft + Evidence)
- Portfolio map of registrations/notifications in scope, linked to SKUs and label/IFU variants.
- Clear definition of roles for the successor (new holder) and previous holder.
- Draft petition subjects mapped to ANVISA’s transfer and cancellation-by-transfer services.
- Document checklist and evidence structure to support each petition.
ANVISA Petition Pack
- Draft of the successor’s transfer petition in ANVISA’s Solicita system, aligned with RDC 903/2024 and related guidance.
- Draft of the previous holder’s cancellation-by-transfer petition, mirroring the successor’s submission where required.
- Fee and protocol tracking overview, so you can see status at each stage.
Legal Dates & Notices Plan
- Target and expected effective dates for transfer and cancellation resolutions.
- Clear statement of responsibilities before, during, and after the transfer (successor vs. previous holder vs. distributors).
- Draft structure for distributor and customer notices, aligned with the planned dates and legal milestones.
Label & IFU Update Plan
- Identification of where the holder appears on labels and IFUs and how it must change.
- Practical plan for controlled changeover (e.g., from batch X onwards) while managing existing printed stock.
- Guidance on how to deplete old stock and align import/marketing periods with published resolutions.
Status Tracking & Publication File
- Centralised tracking of petitions, fees, protocols, and ANVISA interactions.
- Consolidated file of transfer and cancellation publications for audits and inspections.
- Simple, repeatable structure for future transfers if needed.
Representation and documentation only. No laboratory testing or label artwork design are included.
How We Work on BRH Change/Transfer (5 Steps)
We turn ANVISA’s BRH transfer process into a clear, auditable project from first scoping to label/IFU changeover.
Discovery & scope
Route & roles
Petition preparation
Submission & tracking
Label/IFU updates
Inputs We Need From Your Team
- Corporate documents clarifying the relationship between successor and previous holder (merger, acquisition, assignment, change-of-distributor rationale, etc.).
- Current registration and notification numbers, portfolio list, SKUs, and label/IFU files showing holder identification.
- Contact points at the previous holder to coordinate the paired cancellation-by-transfer petition.
- Any contractual constraints affecting stock, distribution, or label change timing.
Why Teams Choose Sobel for BRH Transfer Projects
We convert ANVISA’s process and FAQs into a clean, auditable transfer file—with exact petitions, dates, and label steps—so you avoid rework and confusion.
- Critical, pragmatic interpretation of RDC 903/2024 and ANVISA’s transfer service into a practical project plan.
- Balanced handling of successor vs. previous holder obligations, making sure both sides understand their petitions and timing.
- Precise focus on legal dates, documentation, and label/IFU identification to withstand audits and inspections.
- Market continuity as a core design parameter: stock, distribution, and publication dates planned together.
- Experience in Brazil regulatory projects where ownership and distribution models change due to M&A or strategic shifts.
FREQUENTLY ASKED QUESTIONS
The ownership of the registration or notification—the license holder in Brazil—is transferred. The successor becomes the new holder of record, and the previous holder files a cancellation-by-transfer. The product’s technical characteristics are not changed as part of this process.
In practice, many companies choose to file a new notification rather than use the formal transfer route, often due to timing and process considerations. This is handled on a case-by-case basis based on portfolio and urgency.
Typically, stock produced before publication of the transfer and cancellation resolutions may continue to be imported or marketed by the new holder, subject to ANVISA rules and proper documentation. The transfer plan clarifies dates, responsibilities, and evidence.
Timelines depend on dossier completeness, signature processes with the successor and previous holder, and ANVISA processing times. We provide a structured schedule and an evidence tracker so you can monitor progress.
No. We define what needs to change and where, and we plan the holder identification changeover, but label artwork design and printing are out of scope.
No technical changes are made as part of the transfer. If technical modifications are required, they follow separate ANVISA pathways. For the BRH transfer, the focus is on the legal holder, petitions, dates, and labeling.
Plan a BRH Transfer That Survives Audits and Protects Supply
If you need to change your Brazilian Registration Holder, you cannot treat it as a simple name swap. Sobel structures the successor and previous holder petitions, maps the process to RDC 903/2024, and plans the label/IFU switchover—so your transfer is documented, auditable, and does not interrupt market supply.
Contact Us
We would love to speak with you.
Feel free to reach out using the below details.
